Ordering Recommendation
Use to screen for mast cell activation disorders.
Mnemonic
Methodology
Quantitative Liquid Chromatography-Tandem Mass Spectrometry/Colorimetry
Performed
Varies
Reported
3-9 days
New York DOH Approval Status
Specimen Required
Patients taking aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) may have decreased concentrations of prostaglandin F2 alpha. If possible, discontinue for 2 weeks or 72 hours, respectively, prior to specimen collection.
Urine.
Transfer 5 mL urine to ARUP Standard Transport Tubes. (Min: 4 mL)
Test is not performed at ARUP; separate specimens must be submitted when multiple tests are ordered.
Refrigerated. Also acceptable: Frozen.
Ambient: 8 hours; Refrigerated: 2 weeks; Frozen: 1 month
Reference Interval
By Report
Interpretive Data
Performed by non-ARUP Laboratory
Note
Elevated levels of 2,3-dinor-11beta-prostaglandin F2 alpha (2,3 BPG) in urine are not specific for systemic mast cell disease and may be found in patients with angioedema, diffuse urticaria, or myeloproliferative diseases in the absence of diffuse mast cell proliferation.
Hotline History
Hotline History
CPT Codes
84150; 82570
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
3004161 | 2,3 Dinor-11Beta-Prostaglandin F2a, U | |
3004162 | Creatinine, Random Urine |
Aliases
- 11 Beta-Prostaglandin F2 Alpha
- 11BPG
- 2, 3 11 Beta-Prostaglandin F2 Alpha
- 23BPG
- BPG2
- Mastocytosis
- Prostaglandin
Mayo Clinic Laboratories